Where it comes from
- Made in
- Hypothalamus, locus coeruleus, dorsal root ganglia, pituitary, gut and pancreas
- Sent out by
- Fat intake, stress and nerve injury raise it
- Acts on
- Hypothalamus (feeding, especially fat)
- Locus coeruleus (mood)
- Hippocampus (memory)
- Spinal cord (pain)
- Islets (insulin)
What it does
- Drives alcohol intake in rodents; its pull towards fat specifically failed to replicate in one laboratory 2
- Holds down seizures in the hippocampus; it cuts acetylcholine release in the ventral hippocampus, though what that does to memory is disputed 2
- Rises hugely in injured sensory neurons; in Alzheimer’s disease galanin fibres hyperinnervate the surviving cholinergic neurons, which now reads as protective 2
In medicine
- No medicine copies it or blocks it. Galanin is a research marker in nerve injury and a drug target in epilepsy and depression 2
- Its three receptors are the practical obstacle: GALR1, GALR2 and GALR3 do different things in the same brain, and no ligand selective enough to separate them has reached people 2
Beyond the body’s own use
- Stabilised galanin analogues reduced seizure severity in animal models of epilepsy, though not in every model; the best studied of them worked after injection into the bloodstream, which plain galanin does not, and none has reached people 3
- Variants of the galanin gene and of its GALR3 receptor were linked with alcohol dependence in two populations by one laboratory, and have not been replicated independently 2
- Nothing containing galanin is approved or obtainable outside the laboratory. What is being asked of it is whether a brake on seizures the brain already uses can be imitated by a molecule small enough to get in 3
Sources
- Tatemoto et al., Galanin, a novel biologically active peptide from porcine intestine, FEBS Letters 1983
- Lang et al., Physiology, signalling and pharmacology of galanin peptides and receptors, Pharmacological Reviews 2015
- White et al., Characterization of NAX 5055, a systemically active galanin analogue, in epilepsy models, Neurotherapeutics 2009
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.